Vandana Singh

[ad_1] Novartis AG NVS has announced results from a new pooled exploratory analysis of the MONALEESA Phase 3 program of Kisqali + endocrine therapy (ET) in advanced breast cancer patients. In…

[ad_1] Bloomberg When The Bank Error Is Not In Your Favor: Pay Back $500 Million Citigroup Inc C has won an appeal to retrieve $500 million that was sent…

[ad_1] Needham upgraded Penumbra Inc PEN to Buy from Hold, with a price target of $244. The analyst notes that management indicated PEN is seeing stronger growth in 3Q22 due to…

[ad_1] AstraZeneca plc AZN and Merck & Co Inc MRK announced long-term follow-up results from the Phase 3 PAOLA-1 and SOLO-1 trials in first-line advanced ovarian cancer evaluating Lynparza (Olaparib) as a combination and…

[ad_1] The FDA alerted healthcare providers about the potential for clip lock malfunctions with Abbott Laboratories ABT MitraClip’s delivery system to stop heart valve leakage. “These events appear to occur…

[ad_1] Reuters iPhone 14 Will Be Available In Russia Despite Apple’s Exit From The Country, Says Trade Minister The newly-launched iPhone 14 and other Apple Inc AAPL products will…

[ad_1] Biophytis SA BPTS released topline results from its phase 2-3 COVA study evaluating Sarconeos (BIO101) in treating COVID-19-related respiratory failure. In the primary analysis, Sarconeos reduced by 39% the risk…

[ad_1] BioVie Inc BIVI announced topline results from an investigator-Sponsored Phase 2 trial of NE3107 for Alzheimer’s Disease (AD).  The company says that NE3107 is pursuing a two-pronged approach targeting neuroinflammation…

[ad_1] The European Commission has approved Gilead Science Inc GILD company Kite Pharma’s CAR T-cell therapy Tecartus (brexucabtagene autoleucel) for patients 26 years and above with relapsed or refractory B-cell precursor acute…

[ad_1] Deutsche Bank AG’s DB CEO Christian Sewing warned that China was a considerable risk for Germany and that Europe needed big banks to stave off competition from U.S. banks, Reuters reported.…

[ad_1] In separate SEC documents, Target Corporation TGT filed to raise about $1 billion in bonds due 2032 and McDonald’s Corp MCD about $1.5 billion in two-part bonds due 2052 and 2032. As per the Reuters…

[ad_1] Reuters EQT Corp Close To Buying THQ Appalachia U.S.-based natural gas producer EQT Corporation EQT is in advanced talks to purchase exploration and production company THQ Appalachia I…

[ad_1] Spero Therapeutics Inc SPRO received minutes from a recent Type A meeting with the FDA, discussing steps required to resubmit the marketing application for tebipenem HBr for complicated urinary tract infection…

[ad_1] The FDA approved AstraZeneca plc’s AZN Imfinzi (durvalumab) for locally advanced or metastatic biliary tract cancer (BTC) in combination with chemotherapy (gemcitabine plus cisplatin). The approval was based on the…

[ad_1] Eiger BioPharmaceuticals Inc EIGR updated its planned request for emergency use authorization (EUA) of peginterferon lambda for mild-to-moderate COVID-19. The FDA indicated that it is not yet able to determine…

[ad_1] Regeneron Pharmaceuticals Inc REGN and Sanofi SA SNY announced results from a Phase 3 open-label extension trial of Dupixent (dupilumab) as maintenance therapy in asthma patients aged 6 to 11. The trial…

[ad_1] Shell Plc SHEL is looking for a new CEO, as Chief Executive Ben van Beurden is preparing to step down next year after nearly a decade, two company sources told…

[ad_1] Wall Street Journal Disney Seeks To Pull Off An Amazon With ‘Prime-Like’ Bundle Service Walt Disney Company DIS is reportedly planning to ape a tried-and-tested route to rope…

[ad_1] HC Wainwright has downgraded ObsEva SA OBSV from a Buy to Neutral without a price target. Late last month, the FDA notified ObsEva of review issues regarding deficiencies in the linzagolix application for…

[ad_1] by Vandana Singh, Benzinga Editor August 30, 2022 3:00 PM | 1 min read RBC Capital Markets cut the price target on Catalent Inc CTLT from $155 to $125 with an Outperform…

[ad_1] HC Wainwright has increased the price target on Rockwell Medical Inc RMTI from $3 to $8, with a Buy rating, reflecting a 1-for-11 reverse stock split effected in May and a renewed focus…

[ad_1] The FDA has accepted for priority review Sanofi SA’s SNY marketing application for efanesoctocog alfa (BIVV001) for hemophilia A, a rare bleeding disorder.  The target action date for the FDA…

[ad_1] Longeveron Inc. LGVN announced that the European Patent Office (EPO) had issued a notice of its intent to grant the Company a patent (EP Application No. 15861319.0) related to…

[ad_1] Longeveron Inc. LGVN announced that the European Patent Office (EPO) had issued a notice of its intent to grant the Company a patent (EP Application No. 15861319.0) related to…

[ad_1] Longeveron Inc. LGVN announced that the European Patent Office (EPO) had issued a notice of its intent to grant the Company a patent (EP Application No. 15861319.0) related to…